Seagen Inc
NASDAQ:SGEN
Seagen Inc
NASDAQ:SGEN
Price:
228.74 USD
-0.07%
Market Closed
Updated:
May 7, 2024
Seagen Inc
Cash from Financing Activities
|
Seagen Inc
Cash from Financing Activities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Seagen Inc
NASDAQ:SGEN
|
Cash from Financing Activities
$124.7m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
12%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Financing Activities
-$17.2B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-17%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Financing Activities
-$5.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Financing Activities
$21B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
23%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Financing Activities
-$562.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Financing Activities
-$1.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-88%
|
CAGR 10-Years
N/A
|
See Also
What is Seagen Inc's Cash from Financing Activities?
Cash from Financing Activities
124.7m
USD
124.7m
USD
Based on the financial report for Sep 30, 2023, Seagen Inc's Cash from Financing Activities amounts to 124.7m USD.
What is Seagen Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
12%
12%
Over the last year, the Cash from Financing Activities growth was 51%. The average annual Cash from Financing Activities growth rates for Seagen Inc have been 7% over the past three years , -30% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet
